Jazz Pharmaceuticals PLC (JAZZ)
109.93
+0.66
(+0.60%)
USD |
NASDAQ |
Apr 19, 16:00
109.93
0.00 (0.00%)
After-Hours: 20:00
Jazz Pharmaceuticals Cash from Operations (TTM): 1.092B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.092B |
September 30, 2023 | 1.267B |
June 30, 2023 | 1.377B |
March 31, 2023 | 1.384B |
December 31, 2022 | 1.272B |
September 30, 2022 | 1.108B |
June 30, 2022 | 963.83M |
March 31, 2022 | 702.49M |
December 31, 2021 | 778.51M |
September 30, 2021 | 787.02M |
June 30, 2021 | 770.85M |
March 31, 2021 | 911.68M |
December 31, 2020 | 899.65M |
September 30, 2020 | 801.18M |
June 30, 2020 | 880.79M |
March 31, 2020 | 847.12M |
December 31, 2019 | 776.40M |
September 30, 2019 | 906.70M |
June 30, 2019 | 790.67M |
March 31, 2019 | 833.80M |
December 31, 2018 | 798.90M |
September 30, 2018 | 785.37M |
June 30, 2018 | 752.79M |
March 31, 2018 | 695.91M |
December 31, 2017 | 693.09M |
Date | Value |
---|---|
September 30, 2017 | 669.22M |
June 30, 2017 | 613.35M |
March 31, 2017 | 605.28M |
December 31, 2016 | 592.39M |
September 30, 2016 | 531.44M |
June 30, 2016 | 573.48M |
March 31, 2016 | 587.04M |
December 31, 2015 | 531.94M |
September 30, 2015 | 546.46M |
June 30, 2015 | 501.08M |
March 31, 2015 | 435.44M |
December 31, 2014 | 407.61M |
September 30, 2014 | 352.38M |
June 30, 2014 | 353.47M |
March 31, 2014 | 287.26M |
December 31, 2013 | 288.43M |
September 30, 2013 | 313.74M |
June 30, 2013 | 227.10M |
March 31, 2013 | 295.35M |
December 31, 2012 | 249.75M |
September 30, 2012 | 189.07M |
June 30, 2012 | 190.98M |
March 31, 2012 | 151.44M |
December 31, 2011 | 151.60M |
September 30, 2011 | 130.73M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
702.49M
Minimum
Mar 2022
1.384B
Maximum
Mar 2023
964.02M
Average
899.65M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
Alkermes PLC | 401.35M |
Endo International PLC | 435.10M |
Medtronic PLC | 6.47B |
Perrigo Co PLC | 405.50M |
Iterum Therapeutics PLC | -39.33M |